What will the impact be of use of tirzepatide in patients with obstructive sleep apnea (OSA)?
- Pack, Allan
- Grunstein, Ronald
- Mokhlesi, Babak
- Ryan, Silke
- Schwab, Richard
- Gozal, David
Division of Sleep Medicine/Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
Chronobiology and Sleep Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
Woolcock Institute of Medical Research, Macquarie University, Sydney, Australia
Faculty of Medicine and Health, University of Sydney, Sydney, Australia
RPA-Charles Perkins Centre Clinic, Royal Prince Alfred Hospital, Sydney, Australia
Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Rush University Medical Center, Chicago, IL, USA
Pulmonary and Sleep Disorders Unit, St. Vincent’s University Hospital, Dublin, Ireland
School of Medicine, University College Dublin, Dublin, Ireland
Division of Sleep Medicine/Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
Chronobiology and Sleep Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
Department of Pediatrics and Office of the Dean, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA
Corresponding author. Allan Pack, Division of Sleep Medicine/Department of Medicine, University of Pennsylvania Perelman School of Medicine, 125 South 31st Street, Suite 2100, Philadelphia, PA 19104, USA. Email: [email protected].
Received September 19, 2024
Received in revised form January 16, 2025
Revised April 04, 2025
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
